Research - Brest, Brittany, France
KALSIOM is a biotech company founded in April 2020 and based in Brest, France, discovering and developing first-in-class therapies to treat auto-immunes disorders (AID) involving B-cell dysfunction with a high medical need.The company is focusing on developing first-in-class monoclonal antibodies modulating calcium-signaling pathways in lymphocytes.
Outlook
Apache
WordPress.org
Google Font API
Mobile Friendly